Bone loss associated with hyperprolactinemia in patients with schizophrenia.

  title={Bone loss associated with hyperprolactinemia in patients with schizophrenia.},
  author={Bruce J. Kinon and Hong Liu-Seifert and Virginia L. Stauffer and Jayanthi Jacob},
  journal={Clinical schizophrenia & related psychoses},
  volume={7 3},
BACKGROUND Elevated prolactin (hyperprolactinemia) has been commonly reported during treatment with some antipsychotic drugs. A decrease in bone mineral density (BMD) may be related to elevated prolactin. The objective of this study was to determine the prevalence of low BMD in patients with schizophrenia treated with conventional antipsychotics or risperidone and to evaluate any potential relationship with treatment. METHODS A large-scale, cross-sectional secondary analysis was performed to… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
9 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…